Shahzad Moazzam, Chaudhary Sibgha Gull, Anwar Iqra, Arslan Muhammad, Naseem Zehra, Fatima Naira T, Abbas Sakina, Ali Tayyaba, Siddiqui Raheel S, Hematti Peiman, Abhyankar Sunil H, McGuirk Joseph P, Mushtaq Muhammad Umair
Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, MO, United States.
Department of Medicine, St Mary's Medical Center, Huntington, WV, United States.
Front Med (Lausanne). 2022 Jun 6;9:872692. doi: 10.3389/fmed.2022.872692. eCollection 2022.
We conducted a bibliometric analysis to identify scholarly impact and factors associated with the top 100 cited articles on clinical hematopoietic stem cell transplantation (HSCT). In January 2021, a title-specific search was conducted. Non-HSCT and pre-clinical ( and animal) studies were excluded. A total of 39,406 records were identified and a list of the top 100 articles was made. Articles included in our study were characterized by the citations received, publication year, topic, study design, authors, h-index, and institutions. Linear regression analyses were performed. The 100 most cited articles were published over 52 years from 1968 to 2020, with a maximum number of articles ( = 40) published in the 1990s decade. Top-100 articles were cited 62,002 times with a median citation count of 465 (range 336-2240). The top-cited articles originated from 12 countries. United States contributed 69 articles. The University of Washington Fred Hutchinson Cancer Center ( = 15) was the leading institution. Blood ( = 32) and New England Journal of Medicine ( = 31) made the greatest contribution, and 52 manuscripts were clinical trials. The first author's H-index significantly correlated with citation count while journal impact factor, years since publication, first author's gender, and the number of authors did not have a significant association with the number of citations. In a multivariate regression model, the first author's h-index (regression coefficient 5.46, 95% confidence interval 2.99 to 7.93, < 0.001) independently correlated with the citation count. Our study highlights the most influential articles on clinical HSCT and provides valuable insight for future research needs of the specialty.
我们进行了一项文献计量分析，以确定与临床造血干细胞移植（HSCT）领域被引用次数排名前100的文章相关的学术影响力和因素。2021年1月，我们进行了特定标题搜索。非HSCT和临床前（及动物）研究被排除在外。共识别出39406条记录，并列出了前100篇文章的清单。纳入我们研究的文章的特征包括被引用次数、发表年份、主题、研究设计、作者、h指数和机构。进行了线性回归分析。这100篇被引用次数最多的文章发表于1968年至2020年的52年间，其中20世纪90年代发表的文章数量最多（=40篇）。前100篇文章被引用了62002次，中位数引用次数为465次（范围为336 - 2240次）。被引用次数最多的文章来自12个国家。美国贡献了69篇文章。华盛顿大学弗雷德·哈钦森癌症中心（=15篇）是主要机构。《血液》（=32篇）和《新英格兰医学杂志》（=31篇）贡献最大，52篇手稿为临床试验。第一作者的h指数与引用次数显著相关，而期刊影响因子、发表后的年份、第一作者的性别以及作者数量与引用次数没有显著关联。在多变量回归模型中，第一作者的h指数（回归系数5.46，95%置信区间2.99至7.93，P<0.001）与引用次数独立相关。我们的研究突出了临床HSCT领域最具影响力的文章，并为该专业未来的研究需求提供了有价值的见解。
